Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07211919 · ClinicalTrials.gov registry record
Accelerated Transcranial Magnetic Stimulation Intervention for Post-Concussion Syndrome
A clinical trial of Post-Concussion Syndrome and Post-Concussion Symptoms, sponsored by Cognitive FX.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT07211919: Completed study of Post-Concussion Syndrome and Post-Concussion Symptoms, sponsored by Cognitive FX.
NCT07211919 is a study of Post-Concussion Syndrome and Post-Concussion Symptoms that has completed, run by Cognitive FX. The registered enrollment target is 11 participants, below the 59-participant average among 14 other Post-Concussion Syndrome trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07211919, a study of Post-Concussion Syndrome and Post-Concussion Symptoms, has completed, sponsored by Cognitive FX.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This study looks at the effects of accelerated intermittent theta burst stimulation (aiTBS) on patients with chronic and acute post-concussion syndrome. Each participant was treated in an outpatient setting for about 3 hours per day, over 3 days. The participants' symptom survey scores and brain scan data were then compared before and after treatment.
Primary Outcome
PCSS (post-concussion symptom scale) is a 21-question Likert scale questionnaire regarding physical, cognitive, sleep, and emotional symptoms of post-concussion syndrome. Minimum score on the scale is zero, maximum score is 126. Higher score indicates more severe symptoms.
Conditions Studied
Study Locations (1)
Utah
- Cognitive FX TMS Clinic - Provo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2025-07-31 |
What the finished NCT07211919 record still lists
NCT07211919 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 59-participant average among 14 other Post-Concussion Syndrome trials with a reported enrollment target (81% lower).
The record links to 5 conditions, with Post-Concussion Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT07211919 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT07211919 about?
NCT07211919 is a clinical study titled "Accelerated Transcranial Magnetic Stimulation Intervention for Post-Concussion Syndrome". This study looks at the effects of accelerated intermittent theta burst stimulation (aiTBS) on patients with chronic and acute post-concussion syndrome. Each participant was treated in an outpatient setting for about 3 hours per day, over 3 days. The participants' symptom survey scores and brain sca...
What is the current status of trial NCT07211919?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2025-05-01. Estimated completion is 2025-07-31.
What conditions does trial NCT07211919 study?
This clinical trial studies the following conditions: Post-Concussion Syndrome, Post-Concussion Symptoms, Post Concussive Syndrome, Post-Concussive Syndrome, Chronic, Anxiety Disorder Not Otherwise Specified.
Who is sponsoring clinical trial NCT07211919?
This trial is sponsored by Cognitive FX, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07211919 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Concussion Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07211919's enrollment target sits among peer trials
11 14th of 14 higher than 1 of 14 other Post-Concussion Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post-Concussion Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Post-concussion Syndrome and Chiropractic
RECRUITING · NA
-
Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches
RECRUITING
-
Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline
RECRUITING · NA
-
Mobile Subthreshold Exercise Program for Concussion--R01
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI